期刊文献+

CABG术中ACT、CR监测方法的比较 被引量:2

The comparation of the methods of monitoring ACT and CR during CABG
原文传递
导出
摘要 目的冠状动脉旁路移植术(coronary artery bnypassgraft,CABG)围术期常规监测激活凝血时间(activated clottingtime,ACT)和纤维蛋白原(Fibrinogen,Fbg)。通过使用Sonoclot凝血功能分析仪(sonoclot coagulationanalyzer,SCA)与传统凝血检测的ACT(conventional ACT test,c-AcT)和Fbg进行相关性分析,对CABG术中ACT、CR监测方法进行比较。方法选择非体外循环(Off-ump)CABG患者18例(OP组),体外循环(cardiopulmonary bypass,CPB)CABG患者12例(CPB组),分别于诱导后(T0)、首次给肝素(OP组0.8mg/kg,CPB组1.0mg/kg)后5min(T1),追加肝素(0P组达1.5mg/kg,CPB组达3.0mg/kg)后5min(T2),鱼精蛋白中和肝素后5min(T3)4个时间点,取中心静脉血同时测定C-ACT和SCA的3种ACT及CR。结果①T0点,SonACT、kACT、aiACT分别与C-ACT正相关,相关方程分别为:y=83.15+0.37×(R=0.438,P〈0.05);y=71.33+0.43×(R=0.509,P〈0.01);y=56.19+0.78×(R=0.790,P〈0.01)。sonCR、kCR、aiCR与术前Fbg正相关,相关方程分别为:y=1.16+0.09×(R=0.821,P〈0.001);y=1.11+0.09×(R=0.773,P〈0.001);y=1.50+0.06×(R=0.882,P〈0.001)。②T3点与T0点相比,C-ACT差异有统计学意义(P〈0.01),sonACT、kACT、aiACT差异均无统计学意义。③给予低剂量肝素0,8mg/kg和1.0mg/kg时,分别有39%和83%患者C-ACT大于300S,而sonACT大于300s的例数达55%和95%,kACT则是55%和100%;CR的下降值(ACR)占基础值的百分比已达74%-76%和76%-83%。结论①SCA3种ACT与C-ACT正相关性比较:aiACT〉kACT〉sonACT,aiACT相关性最好;cR与Fbg正相关性比较:aiCR〉sonCR〉kCR,aiCR相关性最好。②鱼精蛋白中和肝素后,SCA3种ACT比C-ACT恢复更好。③使用SCA与传统检测相比能够在低剂量肝素(0.8mg/kg-1.0mg/kg)时更敏感地监测ACT和CR。 Objective Activated clotting time (ACT)and fibrinogen (Fbg) are regularly monitored during Coronary Artery Bypass Graft(CABG). We got the results of ACT and CR by using Sonoclot coagulation analyzer(SCA) to canpare with conventional ACT test (C-ACT)and Fbg, and discussed the differences among the various methods of monitoring ACT and CR duning CABG. Methods 30 patients undergoing CABG were divided into 2 groups, off-pump CABG group(OP, n=18)and cardio-pulmonary bypass CABG group (CPB, n=12). Blood samples were collected through C-line to dertermine the value of C-ACT and sonACT, kACT, aiACT, sonCR, kCR and aiCR after induction (T0), 5 minutes after presenting heparin (0.8 mg/kg in OP group, 1.0 mg/kg in CPB group)(Ti), 5 minutes after adding heparin (added to 1.5 mg/kg in OP group, 3.0 mg/kg in CPB group)(T2), 5 minutes after heparin neutralization with protamine(T3). Results ① At point T0, the baseline of the three ACT of SCA all correlates with C mg/kgACT, the correlating equations are y=83.15 +0.37 ×(R =0.438, P〈0.05 ), y=71.33 +0.43 ×(R =0.509, P〈0.01 ), y=56.19 +0.78 ×(R =0.790, P〈 0.01 ), respectively. And the CRs all correlates with Fbg, the correlating equations are y=1.16+0.09×(R=0.821, P〈0.001);y=1.11+ 0.09x(R=0.773, P〈0.001 );y=1.50+0.06×(R=0.882, P〈0.001 ), respectively. ② There is significant difference between To and T3 on the results of C-ACT, P〈0.01, but not the SCA resuhs. ③ When the dose of heparin is low of 0.8mg/kg or1.0mg/kg, the percent of the patients whose C-ACT higher than 300 seconds is 39% or 83%, and whose sonACT and kACT higher than 300 seconds is 55% or more than 92%. The percent of the decrement of CR is 74%-76% or 76%-83%. Conclusion ①The comparation of the correlation: aiACT〉kACT〉SonACT, aiCR〉sonCR〉kCR, So both of aiACT and aiCR are more accruate than the others. ② After heparin neutralization, the recovery of the SCA results are better than C-ACT.③SCA is more sensitive than C-ACT when the dose of heparin is low such as 0.8 mg/kg-1.0 mg/kg.
出处 《国际麻醉学与复苏杂志》 CAS 2010年第1期30-33,55,共5页 International Journal of Anesthesiology and Resuscitation
关键词 SONOCLOT 激活凝血时间 凝集速率 冠状动脉旁路移植术 凝血 sonoclot ACT CR CABG coagulation
  • 相关文献

参考文献8

  • 1Ganter MT, Monn A, Tavakoli R, et al. Monitoring aetivated clotring time for combined heparin and aprotinin applieation: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot. Eur J Cardiothorac Surg, 2006, 30(2):278-284.
  • 2Searles B, Nasrallah F, Darling E, et al. How does the age of a blood sample affect it's activated clotting time? Comparison of eight different devices. J Extra Corpor Technol, 2002, 34(3): 175-177.
  • 3Kamada Y, Yamakage M, Niiya T, et al. Celite-activated viscometer Sonoclot can measure the suppressive effect of tranexamic acid on hyperfibrinolysis in cardiac surgery. J Anesth, 2001, 15(1 ): 17-21.
  • 4Ekback G, Carlsson O, Schott U, et al. Sonoclot coagulation analysis: a study of test variability. J Cardiotharac Vasc Anesth, 1999, 13(4): 393-397.
  • 5武宙阳.Sonoclot凝血与血小板功能分析仪在体外循环中的应用[J].国外医学(麻醉学与复苏分册),2003,24(1):55-57. 被引量:9
  • 6Dalbert S, Ganter MT, Furrer L, et al. Effects of heparin, haemodilution and aprotinin on kaolin-based activated clotting time: in vitro comparison of two different point of care devices. Acta Anaesthesiol Scand, 2006, 50(4): 461-468.
  • 7Ganter MT, Dalbert S, Graves K, et al. Monitoring activated clotting time for combined heparin and aprotinin application: an in vitro evaluation of a new aprotinin-insensitive test using SONOCLOT. Anesth Analg, 2005, 101(2): 308-314.
  • 8Mochizuki T, Olson PJ, Szlam F, et al. Protamine Reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass. Anesth Analg, 1998, 87(4): 781-785.

二级参考文献17

  • 1Shenaq SA, Saleem A. Viscoelastic measurement of clot formation: the sonoclot. In: Ellison N, Jobes DR, eds. Effective Hemostasis in Cardiac Surgery. Philadelphia:W. B. Saunders, 1988,183-193.
  • 2Hett DA, Walker D, Pilkington SN, et al. Sonoclot analysis. Br J Anaesth 1995,75(6) :771-776.
  • 3Kjellberg U, Hellgren M. Sonoclot signature during normal pregnancy. Intensive Care Med, 2000,26(2): 206-211.
  • 4Liszka-Hackzell JJ, Ekback G. Analysis of the information content in Sonoclot data and reconstruction of coagulation test variables. J Med Syst,2002,26(1) :1-8.
  • 5Tuman KJ, Spiess BD, McCarthy RJ, et al. Comparison of viscoelastic measures of coagulation after cardiopulmonary bypass. Anesth Analg, 1989,69( 1 ) :69-75.
  • 6Tetsuya M, Masakazu K. Evaluation of platelet function by Sonoclot analysis compared with other hemos tatic variables in cardiac surgery.Anesth Analg, 1998,87 (6): 1228-1233.
  • 7Hunt BJ. Modifying peri-operative blood loss. Blood Review, 1991,5(2): 168-176.
  • 8Despotis GJ, Joist JH. Anticoagulation and anticoagulantion reversal with cardiac surgery involving cardiopulmonary bypasss: an update. J Cardiothorac Vasc Anesth, 1999,13(4 suppl 1 ): 18-29.
  • 9Mallett SV, Platt M. Role of thrombelastography in bleeding diatheses and regional anaesthesia. Lancet, 1991,338(6) :765-766.
  • 10Chapin JW, Becker GL, Hurlbert BJ, et al. Comparison of thromboelastograph and Sonoclot coagulation analyzer for assessing coagulation status during orthoptic liver transplantation. Transplantation Proceeding, 1989,21 ( 1 ); 35-39.

共引文献8

同被引文献22

  • 1Dzik WH.Predicting hemorrhage using preoperative coagulation screening assays[J].Current Hematology Reports,2004,3(5):324-330.
  • 2Kam PC,Liew S.Traditional Chinese herbal medicine and anaesthesia[J].Anaesthesia,2002,57(11):1083-1089.
  • 3Pfanner G,Koscielny J,Pernerstorfer T,et al.Preoperative evaluation of the bleeding history.Recommendations of the working group on perioperative coagulation of the Austrian society for anaesthesia,resuscitation and intensive care[J].Anaesthesist,2007,56(6):604-611.
  • 4Koscielny J,Tempelhoff GF,Ziemer S,et al.A practical concept for preoperative management of patients with impaired primary hemostasis[J].Clinical and Applied Thrombosis/Hemostasis,2004,10(2):155-166.
  • 5Stainsby D,MacLennan S,Thomas D,et al.Guidelines on the management of massive blood loss[J].British Journal of Anaesthesia,2006,135(5):634-641.
  • 6Kozek-Langenecker S.Management of massive operative blood loss[J].Minerva Anestesiologica,2007,73(7-8):401-415.
  • 7Hiippala ST.Dextran and hydroxyethyl starch interfere with fibrinogen assays[J].Blood Coagulation and Fibrinolysis,1995,6(8):743-746.
  • 8Kozek-Langenecker SA.Perioperative coagulation monitoring[J].Best Pract Res Clin Anaesthesiol,2010,24(1):27-40.
  • 9Di Benedetto P,Baciarello M,Cabetti L,et al.Thrombelastography present and future perspectives in clinical practice[J].Minerva Anestesiologica,2003,69(6):501-509,509-515.
  • 10Coakley M,Reddy K,Mackie I,et al.Transfusion triggers in orthotopic liver transplantation:a comparison of the thromboelastometry analyzer,the thromboelastogram,and conventional coagulation tests[J].J Cardiothorac Vasc Anesth,2006,20(4):548-553.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部